Published in Pain and Central Nervous System Week, December 5th, 2011
"However, conflicting results have led to inconclusive evidence about the effect of 5HTTLPR...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Pain and Central Nervous System Week
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.